Fraunhofer Institute for Toxicology and Experimental Medicine

Highlights 2017 – our annual report

Toxicology of the 21st century, new therapeutic approaches to treat bacterial infections, High-Performance Center Translational Biomedical Engineering. Our highlights in the past year.

more info

A successful step in COPD research

The results of an innovative clinical study have proven a significantly positive effect on the heart function of COPD patients.

more info

Official launch of the iCAIR project

German-Australian collaboration: battling infection and resistance

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment

more info

High-Performance Center Translational Biomedical Engineering

From basic research to clinical testing of medical devices.

more info

P.R.I.T.® exposure system

We offer new approaches for in-vitro testing of inhalable substances.

more info

Fraunhofer ITEM: News

News / 21.6.2018

RespiraTox

The overall aim of the project “RespiraTox” is to develop a QSAR model tool that reliably predicts the human respiratory irritancy potential of chemicals.

News / 1.6.2018

Airborne pollutants

In an interview, Dr. Tanja Hansen explained how airborne pollutants can be detected, identified, and assessed with animal-free methods or only a minimum of animal experiments.

News / 31.5.2018

Important visitors

Germany´s federal minister of research Karliczek and Lower Saxony´s minister Thümler came to update themselves on infection research in Lower Saxony.

News / 25.5.2018

Mathematical Biosciences

Article in "Nature Systems Biology and Applications": Recognizing hidden mechanisms of cell regulation.

 

Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0

Events

21.6.2018

Herrenhausen Symposium

At the Herrenhausen Symposium with the theme “Individualized Infection Medicine – The Future is Now” from June 21 to 23, Fraunhofer ITEM scientists will present recent research performed in this subject area.
Read more

19.6.2018

AACR conference in Montreal

Prof. Dr. Christoph Klein talks about early dissemination of cancer cells and parallel genetic evolution at the metastatic site.
Read more

19.6.2018

ISES-Europe 2018

At the “ISES-Europe 2018” workshop, taking place in Dortmund on June 19 and 20, Fraunhofer ITEM scientists will present three posters giving insights into recent research work.
Read more

4.6.2018

BIO International Convention 2018

This year’s BIO International Convention will take place in Boston, USA, from June 4 to 7, 2018. It is the world's largest biotechnology trade fair, offering excellent opportunities for networking and collaboration. Fraunhofer ITEM will present latest research results (Booth No. 1501).
Read more

Our services and expertise

 

Drug Development

From drug candidate to proof of concept

 

Chemical Safety and Assessment

From risk analysis towards safe products

 

Translational Biomedical Engineering

From idea to safe medical device

 

Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM